ZEMAIRA
NDC 57516-113, alpha-1-proteinase inhibitor human kit, kit, from Fisher Clinical Services Inc..
- Product NDC
- 57516-113
- Status
- Listed
- Labeler
- Fisher Clinical Services Inc.
- Dosage form
- KIT
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125078
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57516-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57516-113-02 | 57516011302 | 1 KIT in 1 CARTON (57516-113-02) * 95 mL in 1 VIAL, SINGLE-DOSE (57516-114-01) * 95 mL in 1 VIAL, SINGLE-DOSE (57516-115-20) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57516-113 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57516-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57516-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.